Chile’s Public Health Institute (ISP) approved the emergency use of Russian-made Sputnik V COVID-19 vaccine on July 21.
With five votes in favor, two abstentions, and one against, ISP authorized Sputnik V for emergency use for those aged over 18 years, bringing the total number of vaccines authorized in the South American country to six.
Other vaccines approved in Chile include Pfizer-BioNTech, AstraZeneca, Johnson & Johnson, Sinovac, and CanSino.
Chile becomes the 69th country to approve the Sputnik V vaccine.
According to scientific journal The Lancelet last February, the Sputnik V vaccine has a 91.6% effectiveness against COVID-19 after two doses.
According to data from Johns Hopkins University, 61.91% of the population — over 11.7 million — in Chile has been fully vaccinated.